BiondVax Pharmaceuticals Price on November 29, 2023

BVXVDelisted Stock  USD 1.35  0.03  2.17%   
If you're considering investing in BiondVax Stock, it is important to understand the factors that can impact its price. As of today, the current price of BiondVax Pharmaceuticals stands at 1.35, as last reported on the 28th of December, with the highest price reaching 1.40 and the lowest price hitting 1.34 during the day. We have found twenty-three technical indicators for BiondVax Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm BiondVax Pharmaceuticals' Standard Deviation of 3.6, risk adjusted performance of (0.13), and Mean Deviation of 2.62 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
BiondVax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
BVXV
Based on monthly moving average BiondVax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BiondVax Pharmaceuticals by adding BiondVax Pharmaceuticals to a well-diversified portfolio.

Related Headline

Avenue Therapeutics Headline on 29th of November 2023

Avenue Therapeutics stock is rising higher on Wednesday following news of an investor taking a 14.5 percent stake in ATXI shares.

BiondVax Pharmaceuticals Valuation on November 29, 2023

It is possible to determine the worth of BiondVax Pharmaceuticals on a given historical date. On November 29, 2023 BiondVax was worth 1.38 at the beginning of the trading date compared to the closed value of 1.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BiondVax Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find BiondVax Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BiondVax Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BiondVax Pharmaceuticals' related companies.
 Open High Low Close Volume
  1.44    1.49    1.33    1.39    19,122  
07/24/2023
  1.38    1.40    1.34    1.35    17,962  
  1.38    1.40    1.34    1.35    0.00  
Backtest BiondVax Pharmaceuticals  |  BiondVax Pharmaceuticals History  |  BiondVax Pharmaceuticals Valuation   PreviousNext  
Open Value
1.38
1.35
Closing Value
1.38
Upside

BiondVax Pharmaceuticals Trading Date Momentum on November 29, 2023

On December 28 2024 BiondVax Pharmaceuticals was traded for  1.35  at the closing time. The top price for the day was 1.40  and the lowest listed price was  1.34 . There was no trading activity during the period 0.0. Lack of trading volume on December 28, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.22% .

BiondVax Pharmaceuticals Fundamentals Correlations and Trends

By evaluating BiondVax Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BiondVax Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BiondVax financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About BiondVax Pharmaceuticals Stock history

BiondVax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BiondVax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BiondVax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BiondVax Pharmaceuticals stock prices may prove useful in developing a viable investing in BiondVax Pharmaceuticals
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. Biondvax Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.

BiondVax Pharmaceuticals Stock Technical Analysis

BiondVax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of BiondVax Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BiondVax Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

BiondVax Pharmaceuticals Period Price Range

Low
December 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

BiondVax Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

BiondVax Pharmaceuticals December 28, 2024 Market Strength

Market strength indicators help investors to evaluate how BiondVax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BiondVax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying BiondVax Pharmaceuticals stock market strength indicators, traders can identify BiondVax Pharmaceuticals entry and exit signals to maximize returns

BiondVax Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BiondVax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of BiondVax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BiondVax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in BiondVax Stock

If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation